Clinical Trials Logo

Endometrial Hyperplasia clinical trials

View clinical trials related to Endometrial Hyperplasia.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04607252 Terminated - Clinical trials for Atypical Endometrial Hyperplasia

Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia

Start date: January 11, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

To verify whether metformin could improve the effect of progestin as fertility-sparing treatment in patients with atypical endometrial hyperplasia(AEH).

NCT ID: NCT00566644 Terminated - Endometrial Cancer Clinical Trials

Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome

Start date: July 2007
Phase: Phase 3
Study type: Interventional

RATIONALE: The use of intrauterine levonorgestrel may prevent atypical endometrial hyperplasia and endometrial cancer in women with hereditary non-polyposis colorectal cancer or Lynch syndrome. It is not yet known whether intrauterine levonorgestrel and observation are more effective than observation alone in preventing atypical endometrial hyperplasia and endometrial cancer in women with hereditary non-polyposis colorectal cancer or Lynch syndrome. PURPOSE: This randomized phase III trial is studying intrauterine levonorgestrel and observation to see how well they work compared with observation alone in preventing atypical endometrial hyperplasia and endometrial cancer in women with hereditary non-polyposis colorectal cancer or Lynch syndrome.

NCT ID: NCT00503581 Terminated - Clinical trials for Stage 0 Uterine Corpus Cancer

Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia

Start date: July 2007
Phase: Phase 2
Study type: Interventional

This randomized phase II trial is studying how well megestrol works in treating patients with endometrial neoplasia or endometrial hyperplasia. Estrogen can cause the growth of endometrial cancer cells. Hormone therapy using megestrol may fight endometrial cancer by blocking the use of estrogen by the abnormal cells.

NCT ID: NCT00123188 Terminated - Clinical trials for Endometrial Hyperplasia

Ultrasound and Endometrial Hyperplasia

Start date: April 2005
Phase: N/A
Study type: Interventional

The investigators hypothesize that endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with metabolic syndrome: diabetes and/or insulin resistance, hypertension, and obesity.